// App-Quantinova.ai

FRI0023 (2018) : Five-year progression of rheumatoid arthritis disease activity and quality of life in 2002 and 2011. have reductions in disease activity in recent years resulted in improvements in quality of life?

Researchers

Presenter

  • L. Carpenter

Principal Investigators

  • S. Norton

  • E. Nikiphorou

  • P. Kiely

  • J. Dixey

  • P. Creamer

  • D. Walsh

  • A. Young

Medical Centers

  • Health Psychology

  • Academic Rheumatology, King's College London

  • Rheumatology, St George’s Hospital, London

  • Rheumatology, The Royal Wolverhampton, Wolverhampton

  • Rheumatology, North Bristol NHS Trust, Bristol

  • Rheumatology, The University of Nottingham, Nottingham

  • Post Graduate Medical School, University of Hertfordshire, Hatfield, UK

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A